This is a good point. All antibodies on the market now are covered by insurance. Bayer's should cost lost because it won't be covered, but it's still going to be very expensive. That should tell you something about how well it works. Let's go even further than that. The fact that they even decided to test an mAb on macaques for hair loss, knowing how expensive mAbs are, means they already expected it to do very well. Yet it apparently even surpassed their expectations. They wrote it the patent that it was "surprisingly effective". Nobody is developing such an expensive treatment if just barely beats out minoxidil and finasteride. They fully believe that this antibody blows minoxidil out of the water. Minoxidil can be had for $5 a month, whereas this antibody will likely cost thousands per month. Bad news for brokecels, but it shows how effective this is expected to be, so in a way it's great news.